Literature DB >> 31757870

Prion disease incidence in the United States: 2003-2015.

Ryan A Maddox1, Marissa K Person2, Janis E Blevins2, Joseph Y Abrams2, Brian S Appleby2, Lawrence B Schonberger2, Ermias D Belay2.   

Abstract

OBJECTIVE: To report the incidence of prion disease in the United States.
METHODS: Prion disease decedents were retrospectively identified from the US national multiple cause-of-death data for 2003-2015 and matched with decedents in the National Prion Disease Pathology Surveillance Center (NPDPSC) database through comparison of demographic variables. NPDPSC decedents with neuropathologic or genetic test results positive for prion disease for whom no match was found in the multiple cause-of-death data were added as cases for incidence calculations; those with cause-of-death data indicating prion disease but with negative neuropathology results were removed. Age-specific and age-adjusted average annual incidence rates were then calculated.
RESULTS: A total of 5,212 decedents were identified as having prion disease, for an age-adjusted average annual incidence of 1.2 cases per million population (range 1.0 per million [2004 and 2006] to 1.4 per million [2013]). The median age at death was 67 years. Ten decedents were <30 years of age (average annual incidence of 6.2 per billion); only 2 of these very young cases were sporadic forms of prion disease. Average annual incidence among those ≥65 years of age was 5.9 per million.
CONCLUSIONS: Prion disease incidence can be estimated by augmenting mortality data with the results of neuropathologic and genetic testing. Cases <30 years of age were extremely rare, and most could be attributed to exogenous factors or the presence of a genetic mutation. Continued vigilance for prion diseases in all age groups remains prudent.
© 2019 American Academy of Neurology.

Entities:  

Mesh:

Year:  2019        PMID: 31757870     DOI: 10.1212/WNL.0000000000008680

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Establishing a committee for antemortem reviews of suspect Creutzfeldt-Jakob disease cases in Ireland.

Authors:  Conor Fearon; Rachel Howley; Seamus Looby; Amber Byrne; Josephine Heffernan; Ciara Heeney; Alan Beausang; Jane Cryan; Michael Farrell; Sean O'Dowd; Francesca Brett
Journal:  Ir J Med Sci       Date:  2022-07-15       Impact factor: 2.089

2.  Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.

Authors:  Emma Jones; Holger Hummerich; Emmanuelle Viré; James Uphill; Athanasios Dimitriadis; Helen Speedy; Tracy Campbell; Penny Norsworthy; Liam Quinn; Jerome Whitfield; Jacqueline Linehan; Zane Jaunmuktane; Sebastian Brandner; Parmjit Jat; Akin Nihat; Tze How Mok; Parvin Ahmed; Steven Collins; Christiane Stehmann; Shannon Sarros; Gabor G Kovacs; Michael D Geschwind; Aili Golubjatnikov; Karl Frontzek; Herbert Budka; Adriano Aguzzi; Hata Karamujić-Čomić; Sven J van der Lee; Carla A Ibrahim-Verbaas; Cornelia M van Duijn; Beata Sikorska; Ewa Golanska; Pawel P Liberski; Miguel Calero; Olga Calero; Pascual Sanchez-Juan; Antonio Salas; Federico Martinón-Torres; Elodie Bouaziz-Amar; Stéphane Haïk; Jean-Louis Laplanche; Jean-Phillipe Brandel; Phillipe Amouyel; Jean-Charles Lambert; Piero Parchi; Anna Bartoletti-Stella; Sabina Capellari; Anna Poleggi; Anna Ladogana; Maurizio Pocchiari; Serena Aneli; Giuseppe Matullo; Richard Knight; Saima Zafar; Inga Zerr; Stephanie Booth; Michael B Coulthart; Gerard H Jansen; Katie Glisic; Janis Blevins; Pierluigi Gambetti; Jiri Safar; Brian Appleby; John Collinge; Simon Mead
Journal:  Lancet Neurol       Date:  2020-09-16       Impact factor: 44.182

Review 3.  The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.

Authors:  Neil Watson; Jean-Philippe Brandel; Alison Green; Peter Hermann; Anna Ladogana; Terri Lindsay; Janet Mackenzie; Maurizio Pocchiari; Colin Smith; Inga Zerr; Suvankar Pal
Journal:  Nat Rev Neurol       Date:  2021-05-10       Impact factor: 42.937

Review 4.  Clinical Use of Improved Diagnostic Testing for Detection of Prion Disease.

Authors:  Mark P Figgie; Brian S Appleby
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

5.  Tau Protein Phosphorylated at Threonine-231 is Expressed Abundantly in the Cerebellum in Prion Encephalopathies.

Authors:  Vıctor Manuel Gómez-López; Amparo Viramontes-Pintos; Miguel Ángel Ontiveros-Torres; Linda Garcés-Ramírez; Fidel de la Cruz; Ignacio Villanueva-Fierro; Marely Bravo-Muñoz; Charles R Harrington; Sandra Martínez-Robles; Petra Yescas; Parménides Guadarrama-Ortíz; Mario Hernandes-Alejandro; Francisco Montiel-Sosa; Mar Pacheco-Herrero; José Luna-Muñoz
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Human Prion Disease Surveillance in Washington State, 2006-2017.

Authors:  Liliana Sánchez-González; Ryan A Maddox; Larissa C Lewis; Janis E Blevins; Elizabeth J Harker; Brian S Appleby; Marissa K Person; Lawrence B Schonberger; Ermias D Belay; Chas DeBolt; Kathryn H Lofy
Journal:  JAMA Netw Open       Date:  2020-10-01

7.  The first non-prion pathogen identified: neurotropic influenza virus.

Authors:  Suehiro Sakaguchi; Hideyuki Hara
Journal:  Prion       Date:  2022-12       Impact factor: 3.931

Review 8.  Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.

Authors:  Hideyuki Hara; Suehiro Sakaguchi
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

9.  Evaluating drug targets through human loss-of-function genetic variation.

Authors:  Eric Vallabh Minikel; Konrad J Karczewski; Hilary C Martin; Beryl B Cummings; Nicola Whiffin; Daniel Rhodes; Jessica Alföldi; Richard C Trembath; David A van Heel; Mark J Daly; Stuart L Schreiber; Daniel G MacArthur
Journal:  Nature       Date:  2020-05-27       Impact factor: 49.962

10.  Characterization of Prion Disease Associated with a Two-Octapeptide Repeat Insertion.

Authors:  Nicholas Brennecke; Ignazio Cali; Tze How Mok; Helen Speedy; Laszlo L P Hosszu; Christiane Stehmann; Laura Cracco; Gianfranco Puoti; Thomas W Prior; Mark L Cohen; Steven J Collins; Simon Mead; Brian S Appleby
Journal:  Viruses       Date:  2021-09-08       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.